Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Rapamycin (Sirolimus) With Bevacizumab in Patients With Advanced Malignancies

NCT00667485 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT00667485
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00667485 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Rapamycin (Sirolimus) With Bevacizumab in Patients With Advanced Malignancies
Lead sponsor
University of Chicago
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2008
Completion date
May 31, 2012
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer, metastatic cancer